NTRK1 and neoplasm: Fusions in TrkA, TrkB, and TrkC have been demonstrated in several tumor types [40], and heightened signaling through this mechanism has been shown to promote metastatic progression and lead to metastatic progression [41] and poorer prognosis [42].